Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Pneumonia Testing Market Report by Type (Analyzers, Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology (Enzyme-linked Immunosorbent Assay, Immunofluorescence, Western Blot, Polymerase Chain Reaction, Immunohistochemistry, and Others), End User (Hospitals, Diagnostic Laboratories, Homecare, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5176
Buy Now
Market Overview:
The global pneumonia testing market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023 |
|
Forecast Years
|
2024-2032
|
|
Historical Years
|
2018-2023
|
| Market Size in 2023 | US$ 1.8 Billion |
| Market Forecast in 2032 | US$ 2.8 Billion |
| Market Growth Rate (2024-2032) | 5.1% |
Pneumonia is an infection in the lower respiratory tract caused by bacteria, viruses and fungi. It spreads via the inhalation of airborne droplets from the sneeze or cough of an infected person. It leads to inflammation in the air sacs of the lungs and shortness of breath. It also reduces appetite and causes mild fever, dry cough, headaches, fatigue, chills and chest pain. It is diagnosed through pneumonia testing, which includes a physical examination, medical history review, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample.
-(1).webp)
Pneumonia Testing Market Trends:
At present, there is a rise in the utilization of point of care (POC) testing to detect pneumonia on account of its higher efficiency and rapid and accurate test results. This, along with the burgeoning healthcare industry, represents one of the key factors driving the market. Moreover, the introduction of immunochromatographic, pneumococcal urinary antigen (UAT) and advanced nucleic acid detection tests is propelling the growth of the market. In addition, the growing awareness among individuals about the benefits of early diagnosis is augmenting the number of pneumonia testing across the globe. This, coupled with the rising healthcare expenditure by governments of several countries, is contributing to the growth of the market. Besides this, there is an increase in the adoption of enzyme-linked immunosorbent assay (ELISA) to detect pneumonia as it is highly sensitive and easier to carry out. Other growth-inducing factors are the growing geriatric population and rising prevalence of pneumonia among children around the world. Furthermore, key market players are focusing on new product launches and approvals which is projected to bolster the growth of the market.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pneumonia testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, method, technology and end user.
Breakup by Type:
- Analyzers
- Consumables
Breakup by Method:
- Immunodiagnostics
- Molecular Diagnostics
- Point of Care Testing
Breakup by Technology:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
- Enzyme-linked Immunosorbent Assay
- Immunofluorescence
- Western Blot
- Polymerase Chain Reaction
- Immunohistochemistry
- Others
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Homecare
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | US$ Billion |
| Segment Coverage | Type, Method, Technology, End User, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc. |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global pneumonia testing market was valued at US$ 1.8 Billion in 2023.
We expect the global pneumonia testing market to exhibit a CAGR of 5.1% during 2024-2032.
The rising utilization of Point of Care (POC) testing to detect pneumonia, owing to its higher efficiency and rapid and accurate test results, along with the growing consumer awareness regarding the benefits of early diagnosis for pneumonia, is primarily driving the global pneumonia testing market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of pneumonia testing for treating the coronavirus-infected patients associated with pneumonia symptoms.
Based on the type, the global pneumonia testing market has been divided into analyzers and consumables, where analyzers currently exhibit a clear dominance in the market.
Based on the method, the global pneumonia testing market can be categorized into immunodiagnostics, molecular diagnostics, and point of care testing. Currently, point of care testing accounts for the majority of the global market share.
Based on the technology, the global pneumonia testing market has been segregated into enzyme-linked immunosorbent assay, immunofluorescence, western blot, polymerase chain reaction, immunohistochemistry, and others. Among these, enzyme-linked immunosorbent assay currently holds the largest market share.
Based on the end user, the global pneumonia testing market can be bifurcated into hospitals, diagnostic laboratories, homecare, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global pneumonia testing market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More